Eriksson, Ove

The mitochondrial permeability transition

Bernardi, P., Colonna, R., Costantini, P., Eriksson, O., Fontaine, E., Ichas, F., Massari, S., Nicolli, A., Petronilli, V., & Scorrano, L. (1998) · BioFactors

Mitochondrial Function and PathologyCell death mechanisms and regulation

Cited by 183

Current disease modifying approaches to treat Parkinson’s disease

Lindholm, D., Mäkelä, J., Di Liberto, V., Mudò, G., Belluardo, N., Eriksson, O., & Saarma, M. (2016) · Cellular and Molecular Life Sciences

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 99

Nerve growth factor (NGF) and pro‐NGF increase low‐density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth

Do, H. T., Bruelle, C., Pham, D. D., Jauhiainen, M., Eriksson, O., Korhonen, L. T., & Lindholm, D. (2016) · Journal of Neurochemistry

Nerve injury and regenerationCholesterol and Lipid Metabolism

Cited by 37

Depletion of TM6SF2 disturbs membrane lipid composition and dynamics in HuH7 hepatoma cells

Ruhanen, H., Nidhina Haridas, P. A., Eskelinen, E.-L., Eriksson, O., Olkkonen, V. M., & Käkelä, R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Lipid metabolism and biosynthesisCancer, Lipids, and Metabolism

Cited by 37